This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction Note: Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway
Yongping Zhou, Zhiyuan Hua, Ye Zhu, Liying Wang, Fangming Chen, Ting Shan, Yunhai Zhou, Tu Dai
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsUbiquitin and proteasome pathways · Cancer-related gene regulation · Peptidase Inhibition and Analysis
Cancer Cell International (2020) 20:225
10.1186/s12935-020-01288-7
The Editor-in-Chief has retracted this article. After publication, concerns were raised regarding some of the figures, specifically:
- Fig. 1d ARHGAP30, Fig. 2d ARHGAP30 and Fig. 4e b-catenin blots appear to share some of the same bands arranged in different order and orientation.
- The GAPDH western blots in Figures 4e and 5c appear highly similar, and also appear to have been used in another article from a different group that was submitted and published within a similar time frame [1] (now retracted).
The authors have been unable to provide the underlying raw data upon request. The Editor-in-Chief therefore no longer has confidence in the presented data.
Tu Dai has not explicitly stated whether they agree with this retraction. None of the other authors have responded to any correspondence from the editor or publisher about this retraction.